组蛋白去乙酰化酶2缺乏与组蛋白乙酰化 - Suppr

HDAC2 deficiency and histone acetylation.

作者信息

Ree Anne Hansen, Folkvord Sigurd, Flatmark Kjersti

出版信息

Nat Genet. 2008 Jul;40(7):812-3; author reply 813. doi: 10.1038/ng0708-812.

DOI:10.1038/ng0708-812

PMID:18583969

Abstract

摘要

相似文献

HDAC2 deficiency and histone acetylation.

Nat Genet. 2008 Jul;40(7):812-3; author reply 813. doi: 10.1038/ng0708-812.

Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.

Cancer Res. 2008 Apr 1;68(7):2375-83. doi: 10.1158/0008-5472.CAN-07-5807.

A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.

Nat Genet. 2006 May;38(5):566-9. doi: 10.1038/ng1773. Epub 2006 Apr 16.

Modulation of immunoglobulin gene conversion frequency and distribution by the histone deacetylase HDAC2 in chicken DT40.

Genes Cells. 2008 Mar;13(3):255-68. doi: 10.1111/j.1365-2443.2008.01166.x.

Molecule of the month. Vorinostat.

Drug News Perspect. 2006 Jul-Aug;19(6):352.

Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent.

Bioorg Med Chem. 2005 Jul 1;13(13):4332-42. doi: 10.1016/j.bmc.2005.04.002.

Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1.

Cell Death Differ. 2005 Apr;12(4):395-404. doi: 10.1038/sj.cdd.4401567.

Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.

Oncotarget. 2016 Jul 12;7(28):44505-44521. doi: 10.18632/oncotarget.9887.

Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):546-52. doi: 10.1016/j.ijrobp.2009.01.068.

Histone deacetylase inhibitors in cancer therapy.

Cancer Invest. 2006 Aug-Sep;24(5):521-7. doi: 10.1080/07357900600814979.

引用本文的文献

HDAC2-Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple-Negative Breast Cancer.

Adv Sci (Weinh). 2025 Apr;12(14):e2413121. doi: 10.1002/advs.202413121. Epub 2025 Feb 14.

The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracil.

Cell Biol Toxicol. 2023 Oct;39(5):2401-2419. doi: 10.1007/s10565-022-09731-3. Epub 2022 May 24.

Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy.

Cancer Res Treat. 2017 Apr;49(2):374-386. doi: 10.4143/crt.2016.080. Epub 2016 Jul 28.

Biomarkers of treatment toxicity in combined-modality cancer therapies with radiation and systemic drugs: study design, multiplex methods, molecular networks.

Int J Mol Sci. 2014 Dec 9;15(12):22835-56. doi: 10.3390/ijms151222835.

Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy.

PLoS One. 2014 Feb 25;9(2):e89750. doi: 10.1371/journal.pone.0089750. eCollection 2014.

Making sense of HDAC2 mutations in colon cancer.

Gastroenterology. 2008 Nov;135(5):1457-9. doi: 10.1053/j.gastro.2008.09.039. Epub 2008 Oct 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

HDAC2 deficiency and histone acetylation.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献